Hyperthyroidism (overactive thyroid): existing guidance
Hyperthyroidism means that the thyroid is producing too much hormone. Symptoms may include palpitations, tremor, heat intolerance, weight loss, anxiety or disturbed sleep. Because these symptoms can overlap with sarcoidosis or medicine effects, blood tests are important. A healthcare professional should interpret thyroid results and decide on treatment; do not change thyroid or other medicines without advice.
The following is a translation of the Croatian research article about hypothyroidism (underactive thyroid).
Hypothyroidism and sarcoidosis
White female patients may face a higher risk of hypothyroidism
Author: Marta Figueiredo, PhD
White women with sarcoidosis and involvement of multiple organs may be at higher risk of hypothyroidism, or low thyroid activity, than other people with the overactive immune-system disorder, according to a study of more than 3,800 patients in the United States.
In fact, hypothyroidism, which is significantly associated with fatigue, depression, fibromyalgia, obesity and sleep-disordered breathing, was reported in 14% of patients with sarcoidosis, the data showed.
Although the causes of hypothyroidism in patients with sarcoidosis remain unclear, these findings suggest that the possibility of an underactive thyroid should be assessed as a potential coexisting condition. This is particularly the case in patients with multiple-organ involvement, fatigue and depression, the researchers noted.
The study, “Prevalence and characteristics of self-reported hypothyroidism and its association with non-organ-specific manifestations in US patients with sarcoidosis: a nationwide registry study”, was published in ERJ Open Research.
Sarcoidosis is a highly variable inflammatory disease that can lead to the formation of small abnormal lumps or nodules, called granulomas, in almost any organ of the body, most often the lungs.
Previous studies have shown that patients with sarcoidosis have a higher risk of hypothyroidism and abnormal production of antibodies against the thyroid, which also reduces its activity.
However, the exact frequency, clinical characteristics and impact of hypothyroidism in patients with sarcoidosis remain largely unknown.
To address this gap in knowledge, researchers in the United States, in collaboration with the Foundation for Sarcoidosis Research (FSR), analysed data from 3,822 patients with sarcoidosis who answered FSR’s questionnaire for its advanced registry for sarcoidosis treatment between June 2014 and August 2019.
The self-reported, web-based questionnaire provided information about demographics, diagnosis, organ involvement, manifestations such as hypothyroidism, physical and psychosocial impact, and sarcoidosis treatment.
According to the researchers, this was the largest published study to assess the frequency, characteristics and potential impact of an underactive thyroid in patients with sarcoidosis.
The results showed that hypothyroidism was reported by 538 (14.1%) patients, who were significantly older (45.1 versus 43.1 years) and more often female (90% versus 71%) and white (91% versus 78%) than those who did not report the thyroid condition.
This frequency of hypothyroidism was “markedly higher than that reported in the general population, which ranges between 3% and 7% in the United States”, the researchers wrote. However, it was similar to “what has been observed in other smaller sarcoidosis [groups]”, the team wrote.
Notably, 20% of all white female patients included in the study reported symptoms of hypothyroidism.
In addition, a significantly greater proportion of patients with self-reported hypothyroidism reported multiple-organ involvement (51% versus 46%), and more of them had manifestations in the skin, eyes, joints, liver and lacrimal glands, which are involved in tear production.
Coexisting health conditions associated with sarcoidosis or corticosteroid use were also significantly more common in the hypothyroidism group than among those without an underactive thyroid.
The researchers then looked at potential links between hypothyroidism and other manifestations, as the condition had previously been associated with depression, obesity, sleep apnoea, when breathing stops and starts again during sleep, chronic fatigue and fibromyalgia in the general population. It should be noted that fibromyalgia is a condition associated with widespread pain and fatigue.
After adjustment for potential influencing factors, self-reported hypothyroidism was significantly associated with obesity, sleep apnoea, chronic fatigue, depression, antidepressant use and fibromyalgia.
Patients with sarcoidosis and hypothyroidism were also significantly more likely to have missed more than seven working days in the previous year or to have left their jobs because of their illness, suggesting that they experienced greater physical impairment.
When a University of Florida database containing an additional 2,189 adults with sarcoidosis was examined, the researchers obtained similar findings. Notably, a larger proportion of African American patients was included in this group than among the online survey respondents (38% versus 18.5%).
These results showed that 15% of patients had hypothyroidism, which was significantly associated with depression, fatigue, fibromyalgia, obesity and sleep apnoea, suggesting that the study’s findings could be generalised to the overall population of patients with sarcoidosis.
Also, given that chronic fatigue had previously been associated with depression, obesity, sleep apnoea and fibromyalgia, the findings of this study suggest that “fatigue in sarcoidosis is multifactorial and may also be associated with hypothyroidism”, the team wrote.
The data highlighted that “hypothyroidism is a common comorbidity in patients with sarcoidosis, is often associated with multiple-organ sarcoidosis involvement, and may make a potentially reversible contribution to fatigue, depression and physical impairment in this population”, they added.
“We recommend considering routine screening for hypothyroidism in patients with sarcoidosis, particularly those with multiple-organ sarcoidosis, fatigue and depression”, the researchers wrote.
Nevertheless, it remains unclear whether hypothyroidism in this patient population is caused by the formation and accumulation of granulomas within the thyroid, abnormal immune responses associated with sarcoidosis, or the use of certain medicines that cause hypothyroidism, the team pointed out.
Further research is needed to better understand the causes of hypothyroidism in sarcoidosis, identify common disease-related pathways, and assess the impact of hypothyroidism on non-organ-specific symptoms in patients with sarcoidosis.
Source: https://sarcoidosisnews.com/news/white-female-sarcoidosis-patients-face-higher-risk-hypothyroidism/